Correlation Between Exicure and Seres Therapeutics
Can any of the company-specific risk be diversified away by investing in both Exicure and Seres Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Exicure and Seres Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Exicure and Seres Therapeutics, you can compare the effects of market volatilities on Exicure and Seres Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Exicure with a short position of Seres Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Exicure and Seres Therapeutics.
Diversification Opportunities for Exicure and Seres Therapeutics
0.09 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Exicure and Seres is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Exicure and Seres Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seres Therapeutics and Exicure is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Exicure are associated (or correlated) with Seres Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seres Therapeutics has no effect on the direction of Exicure i.e., Exicure and Seres Therapeutics go up and down completely randomly.
Pair Corralation between Exicure and Seres Therapeutics
Given the investment horizon of 90 days Exicure is expected to generate 3.42 times more return on investment than Seres Therapeutics. However, Exicure is 3.42 times more volatile than Seres Therapeutics. It trades about 0.5 of its potential returns per unit of risk. Seres Therapeutics is currently generating about 0.14 per unit of risk. If you would invest 303.00 in Exicure on September 1, 2024 and sell it today you would earn a total of 2,646 from holding Exicure or generate 873.27% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Exicure vs. Seres Therapeutics
Performance |
| Timeline |
| Exicure |
| Seres Therapeutics |
Exicure and Seres Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Exicure and Seres Therapeutics
The main advantage of trading using opposite Exicure and Seres Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Exicure position performs unexpectedly, Seres Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seres Therapeutics will offset losses from the drop in Seres Therapeutics' long position.| Exicure vs. Ikena Oncology | Exicure vs. Eliem Therapeutics | Exicure vs. HCW Biologics | Exicure vs. RenovoRx |
| Seres Therapeutics vs. Syros Pharmaceuticals | Seres Therapeutics vs. Iovance Biotherapeutics | Seres Therapeutics vs. Veracyte | Seres Therapeutics vs. Fate Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Stocks Directory Find actively traded stocks across global markets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |